The District of Massachusetts had consolidated 13 cases against New England Compounding and related companies and individuals for pretrial purposes. The individual cases remain active for case filings. On Jan. 31, the judicial panel on multidistrict litigation (MDL) is scheduled to rule on consolidating cases. To date, the MDL docket lists 80 cases, not including the two just remanded.
Other plaintiffs firms in the consolidated case include several Boston firms: Brown Rudnick; Meehan, Boyle, Black & Bogdanow: Parker Scheer; Shapiro Haber & Urmy; Sheff Law Offices; Sugarman, Rogers, Barshak & Cohen; Thornton & Naumes and Kyros Law Offices in Hingham, Mass.
Plaintiffs firms from elsewhere in the country include: Hagens Berman Sobol Shapiro of Seattle; Winer & Bennett of Nashua; and Mark Zamora & Associates of Atlanta.
New England Compounding's lawyers Alan Winchester, a New York partner at Harris Beach of Rochester, N.Y. and Chicago-based Hinshaw & Culbertson did not respond to requests for comment.
The plaintiffs have also sued sister company Ameridose LLC, which closed last month during a government investigation and Medical Sales Management Inc. The cases also name six individual defendants, including Barry Cadden, an owner, president, head pharmacist and director of pharmacy at New England Compounding until recently.
In November, Saylor IV ordered the attachment of $5 million of the company's assets.
Sheri Qualters writes for The National Law Journal, a Daily Report affiliate.
Subscribe to The National Law Journal
